tiprankstipranks
Advertisement
Advertisement
JCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
PremiumCompany AnnouncementsJCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
30d ago
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
Premium
Company Announcements
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
1M ago
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
Premium
Company Announcements
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
2M ago
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
PremiumCompany AnnouncementsJCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
2M ago
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
Premium
Company Announcements
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
2M ago
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
Premium
Company Announcements
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
2M ago
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
PremiumCompany AnnouncementsJCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
6M ago
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
Premium
Company Announcements
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
6M ago
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
Premium
Company Announcements
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100